Jazz Pharmaceuticals Stock Options

JAZZ Stock  USD 107.14  1.25  1.15%   
Jazz Pharmaceuticals' latest option contracts expiring on 2024-09-20 are carrying combined implied volatility of 44.57 with a put-to-call open interest ratio of 0.07 over 60 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-09-20. The current put volume is at 3.0, with calls trading at the volume of 8.0. This yields a 0.38 put-to-call volume ratio.

Open Interest Against 2024-09-20 Option Contracts

Jazz Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Jazz Pharmaceuticals' lending market. For example, when Jazz Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Jazz Pharmaceuticals, he or she must hedge the risk by shorting Jazz Pharmaceuticals stock over its option's life.
The chart above shows Jazz Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Jazz Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Jazz Pharmaceuticals' option, there is no secondary market available for investors to trade.

Jazz Pharmaceuticals Maximum Pain Price across 2024-09-20 Option Contracts

Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Jazz Pharmaceuticals close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Jazz Pharmaceuticals' option chain provides insight into all available option contracts written on Jazz Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Jazz Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Jazz option contract.

In The Money vs. Out of Money Option Contracts on Jazz Pharmaceuticals

Analyzing Jazz Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Jazz Pharmaceuticals regardless of its overall volatility. This is especially true when Jazz Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Jazz Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Jazz Pharmaceuticals' stock while costing only a fraction of its price.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jazz Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At this time, Jazz Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 12 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 51.5 M in 2024.

Jazz Pharmaceuticals PLC In The Money Call Balance

When Jazz Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Jazz Pharmaceuticals PLC stock is said to be in the money. When it comes to buying Jazz Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Jazz Pharmaceuticals PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Jazz Current Options Market Mood

Jazz Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Jazz Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Jazz Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Jazz Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Jazz Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Rule 16 of the current Jazz contract

Base on the Rule 16, the options market is currently suggesting that Jazz Pharmaceuticals PLC will have an average daily up or down price movement of about 2.79% per day over the life of the 2024-09-20 option contract. With Jazz Pharmaceuticals trading at USD 107.14, that is roughly USD 2.98. If you think that the market is fully incorporating Jazz Pharmaceuticals' daily price movement you should consider buying Jazz Pharmaceuticals PLC options at the current volatility level of 44.57%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Jazz Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Jazz calls. Remember, the seller must deliver Jazz Pharmaceuticals PLC stock to the call owner when a call is exercised.

Jazz Pharmaceuticals Option Chain

When Jazz Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Jazz Pharmaceuticals PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Jazz Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Jazz. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Jazz. It also shows strike prices and maturity days for a Jazz Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
DeltaGammaOpen IntExpirationCurrent SpreadLast Price
Call
2024-09-20 CALL at $55.00.99525.0E-492024-09-2050.0 - 54.661.8In
Call
2024-09-20 CALL at $60.00.92360.0027392024-09-2045.0 - 49.557.5In
Call
2024-09-20 CALL at $65.00.91430.003302024-09-2040.0 - 44.50.0In
Call
2024-09-20 CALL at $70.00.90360.0041222024-09-2035.0 - 39.546.9In
Call
2024-09-20 CALL at $75.00.98470.002172024-09-2030.0 - 34.842.4In
Call
2024-09-20 CALL at $80.00.97730.0033922024-09-2025.0 - 29.937.5In
Call
2024-09-20 CALL at $85.00.98150.003712024-09-2020.0 - 24.831.9In
Call
2024-09-20 CALL at $90.00.96960.006612024-09-2015.0 - 19.919.6In
Call
2024-09-20 CALL at $95.00.95180.012402024-09-2010.2 - 14.80.0In
Call
2024-09-20 CALL at $100.00.84430.0307592024-09-205.6 - 10.414.5In
Call
2024-09-20 CALL at $105.00.62870.04611392024-09-203.5 - 5.64.4In
Call
2024-09-20 CALL at $110.00.41450.03932942024-09-200.95 - 4.72.0Out
Call
2024-09-20 CALL at $120.00.09020.01889672024-09-200.1 - 0.950.35Out
Call
2024-09-20 CALL at $150.00.01410.002313082024-09-200.05 - 0.10.1Out
 Put
2024-09-20 PUT at $100.0-0.15830.0308862024-09-200.15 - 1.20.7Out
 Put
2024-09-20 PUT at $105.0-0.39060.0379192024-09-201.1 - 4.81.2Out
 Put
2024-09-20 PUT at $110.0-0.60810.0453172024-09-203.9 - 6.04.3In
 Put
2024-09-20 PUT at $115.0-0.88460.0319492024-09-205.7 - 10.52.77In
 Put
2024-09-20 PUT at $120.0-0.7460.0198492024-09-2010.5 - 15.013.79In
 Put
2024-09-20 PUT at $125.0-0.92740.012702024-09-2015.5 - 20.218.1In
 Put
2024-09-20 PUT at $130.0-0.80060.012902024-09-2020.5 - 24.922.83In
 Put
2024-09-20 PUT at $135.0-0.80220.01102024-09-2025.5 - 30.20.0In
 Put
2024-09-20 PUT at $140.0-0.97060.004502024-09-2030.5 - 35.426.1In
 Put
2024-09-20 PUT at $145.0-0.97280.003802024-09-2035.5 - 40.40.0In
 Put
2024-09-20 PUT at $150.0-0.97450.003302024-09-2040.5 - 45.40.0In
 Put
2024-09-20 PUT at $155.0-0.97590.002902024-09-2045.5 - 50.40.0In
 Put
2024-09-20 PUT at $160.0-0.84510.006602024-09-2050.5 - 55.20.0In
 Put
2024-09-20 PUT at $165.0-0.8540.006102024-09-2055.5 - 60.10.0In
 Put
2024-09-20 PUT at $170.0-0.98640.001602024-09-2060.5 - 65.30.0In
 Put
2024-09-20 PUT at $175.0-0.97950.00202024-09-2065.5 - 70.40.0In
 Put
2024-09-20 PUT at $180.0-0.86220.005102024-09-2070.5 - 75.20.0In
 Put
2024-09-20 PUT at $185.0-0.86540.004902024-09-2075.5 - 80.20.0In
 Put
2024-09-20 PUT at $190.0-0.8720.004602024-09-2080.5 - 85.10.0In
 Put
2024-09-20 PUT at $195.0-0.98150.001602024-09-2085.5 - 90.40.0In
 Put
2024-09-20 PUT at $200.0-0.98180.001502024-09-2090.5 - 95.40.0In

Jazz Total Stockholder Equity

Total Stockholder Equity

3.92 Billion

At this time, Jazz Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year.

Jazz Pharmaceuticals Corporate Management

Finbar LarkinVP OperationsProfile
George EliadesSenior OfficerProfile
Daniel SwisherNonExecutive EmployeeProfile
Patricia CarrSenior OfficerProfile
Jed MDSenior MedicineProfile
Andrea FlynnVP RelationsProfile

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.